Sware Raises $6M in Series B Funding
Summary
Sware, a Boston, MA-based provider of a software validation solution for innovative life sciences companies, raised $6M in Series B funding. The round was led by First Analysis, with participation from existing investors including LRVHealth, New Stack Ventures and Insight Partners. The company intends to use the funds to bolster research and development of its computer systems validation (CSV) platform, Res_Q, to further streamline processes with artificial intelligence (AI), and to expand its sales team. Led by CEO Ellen Reilly, Sware provides Res_Q™, a software platform that offers complete validation solution eliminating validation debt. It is a cloud-based platform built with an open API architecture that allows organizations to control all validation processes – for IT, manufacturing, lab systems, and more – in a single system.
Funding
Review available funding amount, funding date, investors, and linked company information related to Sware Raises $6M in Series B Funding in the interactive ISVWorld profile.